Publication | Open Access
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors
306
Citations
20
References
2005
Year
MedicinePharmacologyPathologyMalignant TumorsAnti-cancer AgentEgf ReceptorCancer TreatmentClinical EvaluationOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1